세계의 생화학 시약 시장 : 유형별(PCR, 크로마토그래피, 세포 및 조직 배양, 유세포 분석, 전기영동, 면역 측정), 최종 사용자별(제약 및 생명공학, CRO, 진단 실험실, 식품 기업, 학술 기관) - 예측(-2031년)

Biochemical Reagents Market by Type (PCR, Chromatography, Cell & Tissue Culture, Flow Cytometry, Electrophoresis, Immunoassay) End User (Pharmaceutical & Biotechnology, CRO, Diagnostic Laboratories, Food Companies, Academic) - Global Forecast to 2031

US $ 4,175 ￦ 5,747,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회만 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,875 ￦ 8,088,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,875 ￦ 10,841,000

PDF (Global Site License)

PDF 보고서를 동일 기업 및 자회사의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

이 보고서는 생화학 시약 시장 시나리오에 대한 광범위한 2차 연구와 1차 조사 및 심층 분석에 이어 주요 산업 촉진요인, 억제요인, 시장 성장 촉진요인 및 과제에 대한 분석으로 구성되어 있습니다. 이 시장의 성장은 제약 산업에서 생화학 시약에 대한 수요 증가, 만성 질환의 유병률 증가, 제약 및 생명공학 부문의 지속적인 확장, 법의학 및 농업 관련 기업의 생화학 시약 사용 증가, 진단 및 병리 검사실 수 증가로 인해 발생할 수 있습니다. 그러나 시약의 교차 오염에 대한 우려가 시장 성장을 억제하고 있습니다.

또한, 생화학 기술의 발전과 진단용 생화학 시약에 대한 수요 증가는 시장 성장의 기회를 제공할 것으로 예상됩니다. 그러나 생화학 시약의 유통기한이 짧다는 점은 시장 성장에 영향을 미치는 큰 도전이 되고 있습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 인사이트

• 개요
• 성장 촉진요인
• 성장 억제요인
• 기회
• 과제
• 요인 분석
• 동향
• 규제 분석
• 가격 분석
• Porter의 Five Forces 분석

제5장 생화학 시약 시장 평가 : 유형별

• 개요
• PCR 시약
• 크로마토그래피 시약
• 세포 및 조직배양 시약
• 유세포분석기 시약
• 전기영동 시약
• 면역측정 시약
• 기타 시약

제6장 생화학 시약 시장 평가 : 최종사용자별

• 개요
• 제약 기업 및 바이오테크놀러지 기업
• CRO 및 CDMO
• 병원
• 진단 실험실
• 식품 및 음료 기업
• 학술기관 및 연구기관
• 기타 최종사용자

제7장 생화학 시약 시장 평가 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타 유럽(RoE)
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 기타 아시아태평양(RoAPAC)
• 라틴아메리카
  • 브라질
  • 멕시코
  • 기타 라틴아메리카(RoLATAM)
• 중동 및 아프리카

제8장 경쟁 분석

• 개요
• 주요 성장 전략
• 경쟁 벤치마킹
• 경쟁 대시보드
  • 업계 리더
  • 시장 차별화 요인
  • 선행 기업
  • 신규 기업
• 주요 기업별 시장 점유율 분석/시장 순위(2022년)

제9장 기업 개요(기업 개요, 재무 현황, 제품 포트폴리오, 전략 전개 상황)

• Waters Corporation
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• F. Hoffmann-La Roche AG
• Merck KGaA
• Siemens Healthineers AG
• QIAGEN N.V.
• Becton, Dickinson and Company
• Johnson & Johnson
• Abbott Laboratories

(주 : SWOT 분석은 주요 5개사에 대해 제공됩니다)

제10장 부록

LSH

영문 목차

영문목차

The global biochemical reagents market is expected to reach $39.61 billion by 2031 at a CAGR of 6.4% from 2024 to 2031.

Following extensive secondary and primary research and in-depth analysis of the biochemical reagents market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of this market is driven by the growing demand for biochemical reagents in the pharmaceutical industry, the rising prevalence of chronic diseases, the continuous expansion of the pharmaceutical and biotechnology sector, the increasing utilization of biochemical reagents among forensic & agriculture companies, and the rising number of diagnostic and pathology laboratories. However, concerns about reagent cross-contamination restrain the market's growth.

Furthermore, advancements in biochemistry techniques and a rising demand for biochemical reagents for diagnostics are expected to offer market growth opportunities. However, the short shelf life of biochemical reagents is a major challenge impacting the market's growth.

The report offers a competitive landscape based on an extensive assessment of key market players' offerings and geographic presence and the key growth strategies adopted by them over the past few years (2020-2024). The key players operating in the global biochemical reagents market are Waters Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Merck KGaA (U.S.), Siemens Healthineers AG (Germany), QIAGEN N.V. (Germany), Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), and Abbot Laboratories (U.S.).

Among the types covered in this report, in 2024, the chromatography reagents segment is expected to account for the largest share of the biochemical reagents market. The large market share of this segment can be attributed to the increasing use of chromatographic techniques in both basic and applied research and by pharmaceutical and biotech industries for quality control, drug discovery, and pharmaceutical manufacturing. Additionally, increasing applications of chromatography across food, environmental, and forensics, coupled with advancements in chromatography systems, contribute to the segment's significant market share.

Among the end users covered in this report, in 2024, the pharmaceutical & biotechnology research segment is expected to account for the largest share of the biochemical reagents market. The large market share of this segment is attributed to the growing number of research laboratories, increased investments in R&D, and rising funding for pharmaceutical research.

An in-depth analysis of the geographical scenario of the global biochemical reagents market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region.

In 2024, North America is expected to account for the largest share of the biochemical reagents market. North America's major market share is attributed to the large number of pathology & diagnostic laboratories, high R&D expenditure, high prevalence of chronic diseases, and growth in the pharmaceutical industry.

Scope of the Report:

Biochemical Reagents Market Assessment-by Type

• PCR Reagents
• Chromatography Reagents
• Cell & Tissue Culture Reagents
• Flow Cytometry Reagents
• Electrophoresis Reagents
• Immunoassay Reagents
• Other Reagents

Note: Other reagents consist of ISH Reagents, Transcription & Translational Reagents, and Spectrometry Reagents.

Biochemical Reagents Market Assessment-by End User

• Pharmaceutical & Biotechnology Companies
• CROs & CDMOs
• Hospitals
• Diagnostic Laboratories
• Food & Beverage Companies
• Academic & Research Institutes
• Other End Users

Note: Other end users consist of Forensics, Agriculture companies, Oil & Gas Companies, and Environmental Monitoring Agencies.

Biochemical Reagents Market Assessment-by Geography

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K
• Italy
• Spain
• Rest of Europe (Roe)
• Asia-Pacific (APAC)
• China
• Japan
• India
• Rest of Asia-Pacific (RoAPAC)
• Latin America
• Brazil
• Mexico
• Rest of Latin America (RoLATAM)
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency and Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection and Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
• 2.3. Market Sizing and Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Increasing Demand for Biochemical Reagents from the Pharmaceutical Industry
  • 4.2.2. Increasing Prevalence of Chronic and Infectious Diseases
  • 4.2.3. Expansion of the Pharmaceutical & Biotechnology Sector
  • 4.2.4. Increasing Utilization of Biochemical Reagents among Forensic and Agriculture Companies
• 4.3. Restraint
  • 4.3.1. Concerns About Reagent Cross-Contamination
• 4.4. Opportunities
  • 4.4.1. Advancements in Biochemistry Techniques
  • 4.4.2 Increasing Demand for Biochemical Reagents in Diagnostics
• 4.5. Challenges
  • 4.5.1. Short Shelf Life of Biochemical Reagents.
• 4.6. Factor Analysis
• 4.7. Trends
• 4.8. Regulatory Analysis
• 4.9. Pricing Analysis
• 4.10. Porter's 5 Force Analysis

5. Biochemical Reagents Market Assessment-by Type

• 5.1. Overview
• 5.2. PCR Reagents
• 5.3. Chromatography Reagents
• 5.4. Cell & Tissue Culture Reagents
• 5.5. Flow Cytometry Reagents
• 5.6. Electrophoresis Reagents
• 5.7. Immunoassay Reagents
• 5.8. Other Reagents

6. Biochemical Reagents Market Assessment-by End User

• 6.1. Overview
• 6.2. Pharmaceutical & Biotechnology Companies
• 6.3. CROs & CDMOs
• 6.4. Hospitals
• 6.5. Diagnostic Laboratories
• 6.6. Food & Beverage Companies
• 6.7. Academic & Research Institutes
• 6.8. Other End Users

7. Biochemical Reagents Market Assessment-by Geography

• 7.1. Overview
• 7.2. North America
  • 7.2.1. U.S.
  • 7.2.2. Canada
• 7.3. Europe
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Rest of Europe (RoE)
• 7.4. Asia-Pacific
  • 7.4.1. Japan
  • 7.4.2. China
  • 7.4.3. India
  • 7.4.4. Rest of Asia-Pacific (RoAPAC)
• 7.5. Latin America
  • 7.5.1. Brazil
  • 7.5.2. Mexico
  • 7.5.3. Rest of Latin America (RoLATAM)
• 7.6. Middle East and Africa

8. Competition Analysis

• 8.1. Overview
• 8.2. Key Growth Strategies
• 8.3. Competitive Benchmarking
• 8.4. Competitive Dashboard
  • 8.4.1. Industry Leaders
  • 8.4.2. Market Differentiators
  • 8.4.3. Vanguards
  • 8.4.4. Emerging Companies
• 8.5. Market Share Analysis/Market Ranking, by Key Players (2022)

9. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)

• 9.1. Waters Corporation
• 9.2. Thermo Fisher Scientific Inc.
• 9.3. Bio-Rad Laboratories, Inc.
• 9.4. Agilent Technologies, Inc.
• 9.5. F. Hoffmann-La Roche AG
• 9.6. Merck KGaA
• 9.7. Siemens Healthineers AG
• 9.8. QIAGEN N.V.
• 9.9. Becton, Dickinson and Company
• 9.10. Johnson & Johnson
• 9.11. Abbott Laboratories

(Note: SWOT Analysis Will be Provided for the Top 5 companies)

10. Appendix

• 10.1. Available Customization
• 10.2. Related Reports

관련자료